Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Filed with HKEX · Stock code 8037 · · 11 pages · English
Summary by 6ix AI
It confirms the total authorized share capital and provides details on issued shares and public float sufficiency. The report indicates that the company has maintained its issued shares and confirms compliance with public float requirements. The submission is categorized as a new filing under the Exchange Listing Rules.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China Biotech Services Holdings Limited on 6ix
Earlier from China Biotech Services
- Notification Letter to Non-Registered Shareholders
- Notification Letter to Registered Shareholders and Reply Form
- Interim report 2026
- AXA and China Biotech Services Sign Memorandum of Understanding
Follow China Biotech Services into a list and get an email when it puts out news.
Follow China Biotech Services